Hopman Mark Insider Trading -- Recent SEC Form 4 Transactions

Hopman Mark (CIK 2048497) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-25). Recent activity: Sell BBNX (1,258 shares), Sell BBNX (275 shares), Sell BBNX (5,329 shares), Sell BBNX (856 shares), Sell BBNX (2,061 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-06-25Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell1,258$18,880
2026-06-05Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell275$3,385
2026-06-03Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell5,329$67,183
2026-03-16Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell856$25,115
2026-03-16Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell2,061$63,190
2026-03-05Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell353$4,084
2026-03-03Beta Bionics, Inc. (BBNX)Chief Commercial OfficerBuy109,105$0
2026-03-03Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell834$10,308
2025-09-08Beta Bionics, Inc. (BBNX)Chief Commercial OfficerBuy656$3,346
2025-09-08Beta Bionics, Inc. (BBNX)Chief Commercial OfficerBuy4,093$20,874
2025-09-08Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell6,818$136,155
2025-09-08Beta Bionics, Inc. (BBNX)Chief Commercial OfficerBuy11,411$58,196
2025-09-08Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell11,411$234,610
2025-09-04Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell848$15,993
2025-08-20Beta Bionics, Inc. (BBNX)Chief Commercial OfficerBuy16,158$82,406
2025-08-20Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell16,158$268,384
2025-06-04Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell238$4,053
2025-06-04Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell551$10,001
2025-06-04Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSell79$1,477
2025-03-03Beta Bionics, Inc. (BBNX)Chief Commercial OfficerBuy35,000$0

Source: SEC Form 4 filings · as of 2026-06-25